Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study
Agency determines one-month safety data sufficient in first-stage and grants continued enrollment of up to 100 subjects in second stage of sexual function trial ENGLEWOOD, Colo., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE …